Legal & General Group PLC Adaptive Biotechnologies Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Legal & General Group PLC holds 10,832 shares of ADPT stock, worth $70,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,832
Previous 10,832 -0.0%
Holding current value
$70,624
Previous $55,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $3,407 - $5,176
1,011 Added 10.29%
10,832 $55,000
Q2 2024

Aug 14, 2024
SELL
$2.34 - $3.96 $217,842 - $368,656
-93,095 Reduced 90.46%
9,821 $35,000
Q1 2024

May 14, 2024
BUY
$2.88 - $4.8 $13,878 - $23,131
4,819 Added 4.91%
102,916 $330,000
Q4 2023

Feb 15, 2024
SELL
$3.46 - $5.33 $1,176 - $1,812
-340 Reduced 0.35%
98,097 $480,000
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $3,538 - $5,891
-698 Reduced 0.7%
98,437 $536,000
Q2 2023

Aug 14, 2023
BUY
$6.19 - $8.78 $21,504 - $30,501
3,474 Added 3.63%
99,135 $665,000
Q1 2023

May 15, 2023
BUY
$7.8 - $10.11 $10,553 - $13,678
1,353 Added 1.43%
95,661 $844,000
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $9,821 - $14,654
1,569 Added 1.69%
94,308 $720,000
Q3 2022

Nov 14, 2022
SELL
$6.5 - $12.67 $163,962 - $319,600
-25,225 Reduced 21.38%
92,739 $660,000
Q2 2022

Aug 22, 2022
BUY
$6.4 - $14.73 $174,880 - $402,497
27,325 Added 30.15%
117,964 $954,000
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $17,780 - $50,777
1,757 Added 1.98%
90,639 $1.26 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $10,521 - $15,403
418 Added 0.47%
88,882 $2.49 Million
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $473,505 - $628,869
15,773 Added 21.7%
88,464 $3.01 Million
Q2 2021

Aug 12, 2021
BUY
$32.22 - $44.59 $514,231 - $711,656
15,960 Added 28.13%
72,691 $2.97 Million
Q1 2021

May 17, 2021
BUY
$37.26 - $67.74 $39,979 - $72,685
1,073 Added 1.93%
56,731 $2.28 Million
Q4 2020

Feb 12, 2021
SELL
$45.01 - $65.47 $435,201 - $633,029
-9,669 Reduced 14.8%
55,658 $3.29 Million
Q3 2020

Nov 13, 2020
BUY
$35.79 - $48.81 $1.14 Million - $1.55 Million
31,731 Added 94.45%
65,327 $3.18 Million
Q2 2020

Aug 14, 2020
BUY
$24.95 - $48.38 $308,232 - $597,686
12,354 Added 58.16%
33,596 $1.63 Million
Q1 2020

May 14, 2020
BUY
$16.96 - $34.16 $334,620 - $673,976
19,730 Added 1304.89%
21,242 $589,000
Q4 2019

Feb 13, 2020
BUY
$24.56 - $32.8 $16,111 - $21,516
656 Added 76.64%
1,512 $45,000
Q3 2019

Nov 13, 2019
BUY
$30.31 - $53.51 $25,945 - $45,804
856 New
856 $26,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $932M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email